CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: dipyridodiazepine
Accession: CHEBI:63667
browse the term
Definition: An organic heterotricyclic compound whose skeleton consists of a diazepine ring which is fused to two pyridine rings.
Synonyms: related_synonym: dipyridodiazepines
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression
EXP
Nevirapine results in increased expression of ABCB1A mRNA
CTD
PMID:23947594
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Adamts15
ADAM metallopeptidase with thrombospondin type 1 motif, 15
increases expression
ISO
Nevirapine results in increased expression of ADAMTS15 mRNA
CTD
PMID:38636494
NCBI chr 8:29,307,864...29,331,249
Ensembl chr 8:29,307,865...29,331,249
G
Adamts9
ADAM metallopeptidase with thrombospondin type 1 motif, 9
decreases expression
EXP
Nevirapine metabolite results in decreased expression of ADAMTS9 mRNA; Nevirapine results in decreased expression of ADAMTS9 mRNA
CTD
PMID:23947594
NCBI chr 4:125,290,633...125,462,988
Ensembl chr 4:125,291,490...125,462,929
G
Adgrf5
adhesion G protein-coupled receptor F5
increases expression
EXP
Nevirapine metabolite results in increased expression of ADGRF5 mRNA
CTD
PMID:23947594
NCBI chr 9:17,517,596...17,624,107
Ensembl chr 9:17,520,009...17,623,968
G
Adipoq
adiponectin, C1Q and collagen domain containing
increases expression increases secretion
ISO
Nevirapine results in increased expression of ADIPOQ mRNA Nevirapine results in increased secretion of ADIPOQ protein
CTD
PMID:21619898
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adrb2
adrenoceptor beta 2
increases expression
ISO
Nevirapine results in increased expression of ADRB2 mRNA
CTD
PMID:38636494
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Aif1
allograft inflammatory factor 1
decreases expression
EXP
Nevirapine metabolite results in decreased expression of AIF1 mRNA
CTD
PMID:23947594
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
G
Alas1
5'-aminolevulinate synthase 1
increases expression
ISO
Nevirapine results in increased expression of ALAS1 mRNA
CTD
PMID:38636494
NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917
G
Alb
albumin
affects binding
ISO
Nevirapine binds to ALB protein
CTD
PMID:15814459 PMID:16336266
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Apoa1
apolipoprotein A1
increases expression
ISO
Nevirapine results in increased expression of APOA1 protein
CTD
PMID:19667106
NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
G
Ar
androgen receptor
increases expression
ISO
Nevirapine results in increased expression of AR mRNA; Nevirapine results in increased expression of AR protein
CTD
PMID:19152342
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Armcx2
armadillo repeat containing, X-linked 2
decreases expression
EXP
Nevirapine metabolite results in decreased expression of ARMCX2 mRNA; Nevirapine results in decreased expression of ARMCX2 mRNA
CTD
PMID:23947594
NCBI chr X:97,980,662...97,985,523
Ensembl chr X:97,980,660...97,985,552
G
Arnt
aryl hydrocarbon receptor nuclear translocator
increases expression
EXP
Nevirapine metabolite results in increased expression of ARNT mRNA
CTD
PMID:23947594
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
G
Arrdc3
arrestin domain containing 3
decreases expression
ISO
Nevirapine results in decreased expression of ARRDC3 mRNA
CTD
PMID:38636494
NCBI chr 2:11,137,464...11,149,978
Ensembl chr 2:11,137,460...11,149,978
G
Atp1b1
ATPase Na+/K+ transporting subunit beta 1
increases expression
ISO
Nevirapine results in increased expression of ATP1B1 mRNA
CTD
PMID:38636494
NCBI chr13:76,786,580...76,807,096
Ensembl chr13:76,786,578...76,807,459
G
Bmp6
bone morphogenetic protein 6
increases expression
ISO
Nevirapine results in increased expression of BMP6 mRNA
CTD
PMID:32816093
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
G
Casp3
caspase 3
increases cleavage multiple interactions
ISO
Nevirapine results in increased cleavage of CASP3 protein Mifepristone inhibits the reaction [Nevirapine results in increased cleavage of CASP3 protein]
CTD
PMID:38636494
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cd180
CD180 molecule
decreases expression
ISO
Nevirapine results in decreased expression of CD180 mRNA
CTD
PMID:38636494
NCBI chr 2:33,855,940...33,870,046
Ensembl chr 2:33,855,991...33,899,936
G
Cd36
CD36 molecule
increases expression
EXP
Nevirapine metabolite results in increased expression of CD36 mRNA
CTD
PMID:23947594
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
Nevirapine results in increased expression of CDKN1A mRNA
CTD
PMID:38636494
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cebpa
CCAAT/enhancer binding protein alpha
increases expression
ISO
Nevirapine results in increased expression of CEBPA mRNA
CTD
PMID:21619898
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
G
Ces2h
carboxylesterase 2H
increases expression
EXP
Nevirapine results in increased expression of CES2 mRNA
CTD
PMID:23947594
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
G
Ciita
class II, major histocompatibility complex, transactivator
increases expression
ISO
Nevirapine results in increased expression of CIITA
CTD
PMID:26626330
NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440
G
Cish
cytokine inducible SH2-containing protein
decreases expression
ISO
Nevirapine results in decreased expression of CISH mRNA
CTD
PMID:38636494
NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250
G
Cldn5
claudin 5
decreases expression
ISO
Nevirapine results in decreased expression of CLDN5 mRNA
CTD
PMID:38636494
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
G
Clec4a1
C-type lectin domain family 4, member A1
decreases expression
EXP
Nevirapine results in decreased expression of CLEC4A1 mRNA
CTD
PMID:23947594
NCBI chr 4:156,173,894...156,186,009
Ensembl chr 4:156,173,894...156,186,008
G
Clec4a3
C-type lectin domain family 4, member A3
decreases expression
EXP
Nevirapine results in decreased expression of CLEC4A3 mRNA
CTD
PMID:23947594
NCBI chr 4:156,214,030...156,224,818
Ensembl chr 4:156,214,718...156,224,817
G
Clec4m
C-type lectin domain family 4 member M
increases expression
EXP
Nevirapine metabolite results in increased expression of CD209B mRNA
CTD
PMID:23947594
NCBI chr12:1,915,902...1,924,529
Ensembl chr12:1,915,919...1,924,539
G
Cotl1
coactosin-like F-actin binding protein 1
decreases expression
EXP
Nevirapine results in decreased expression of COTL1 mRNA
CTD
PMID:23947594
NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689
G
Cux2
cut-like homeobox 2
decreases expression
EXP
Nevirapine metabolite results in decreased expression of CUX2 mRNA
CTD
PMID:23947594
NCBI chr12:34,507,723...34,707,581
Ensembl chr12:34,520,959...34,705,806
G
Cxcl3
C-X-C motif chemokine ligand 3
decreases expression
ISO
Nevirapine results in decreased expression of CXCL1 mRNA
CTD
PMID:38636494
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
increases expression
EXP
Nevirapine metabolite results in increased expression of CYP2B1 mRNA; Nevirapine results in increased expression of CYP2B1 mRNA
CTD
PMID:23947594
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
multiple interactions increases expression
ISO
[Nevirapine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA; [Nevirapine results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mRNA Nevirapine results in increased expression of CYP2B10 mRNA
CTD
PMID:17041008 PMID:38636494
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
affects binding
EXP
Nevirapine binds to CYP2C11 protein
CTD
PMID:22793666
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
affects binding
ISO
Nevirapine binds to CYP3A4 protein
CTD
PMID:22793666
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
affects binding increases expression
EXP
Nevirapine binds to CYP3A23-3A1 protein Nevirapine results in increased expression of CYP3A23-3A1 mRNA
CTD
PMID:22793666 PMID:23947594
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
increases expression
EXP
Nevirapine results in increased expression of CYP3A9 mRNA
CTD
PMID:23947594
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Cyp4b1
cytochrome P450, family 4, subfamily b, polypeptide 1
increases expression
EXP
Nevirapine metabolite results in increased expression of CYP4B1 mRNA
CTD
PMID:23947594
NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348
G
Dapk1
death associated protein kinase 1
increases expression
EXP
Nevirapine metabolite results in increased expression of DAPK1 mRNA
CTD
PMID:23947594
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
G
Dbp
D-box binding PAR bZIP transcription factor
decreases expression
EXP
Nevirapine metabolite results in decreased expression of DBP mRNA
CTD
PMID:23947594
NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745
G
Dclk3
doublecortin-like kinase 3
decreases expression
ISO
Nevirapine results in decreased expression of DCLK3 mRNA
CTD
PMID:38636494
NCBI chr 8:111,401,544...111,453,999
Ensembl chr 8:111,401,358...111,453,999
G
Ddhd1
DDHD domain containing 1
decreases expression
EXP
Nevirapine results in decreased expression of DDHD1 mRNA
CTD
PMID:23947594
NCBI chr15:18,824,389...18,891,036
Ensembl chr15:18,824,394...18,890,952
G
Ddit4
DNA-damage-inducible transcript 4
increases expression
ISO
Nevirapine results in increased expression of DDIT4 mRNA
CTD
PMID:38636494
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
G
Depdc7
DEP domain containing 7
decreases expression
ISO
Nevirapine results in decreased expression of DEPDC7 mRNA
CTD
PMID:38636494
NCBI chr 3:91,099,111...91,121,152
Ensembl chr 3:91,099,835...91,121,124
G
Dip2a
disco-interacting protein 2 homolog A
increases expression
EXP
Nevirapine results in increased expression of DIP2A mRNA
CTD
PMID:23947594
NCBI chr20:12,284,566...12,371,068
Ensembl chr20:12,284,654...12,370,217
G
Dnajb5
DnaJ heat shock protein family (Hsp40) member B5
increases expression
EXP
Nevirapine metabolite results in increased expression of DNAJB5 mRNA
CTD
PMID:23947594
NCBI chr 5:57,176,840...57,186,067
Ensembl chr 5:57,176,845...57,185,490
G
Dusp1
dual specificity phosphatase 1
increases expression
ISO
Nevirapine results in increased expression of DUSP1 mRNA
CTD
PMID:38636494
NCBI chr10:16,680,478...16,683,275
G
Edem1
ER degradation enhancing alpha-mannosidase like protein 1
increases expression
EXP
Nevirapine results in increased expression of EDEM1 mRNA
CTD
PMID:23947594
NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717
G
Egf
epidermal growth factor
decreases expression
ISO
Nevirapine results in decreased expression of EGF mRNA
CTD
PMID:19152342
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Egfr
epidermal growth factor receptor
decreases expression
ISO
Nevirapine results in decreased expression of EGFR mRNA
CTD
PMID:19152342
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Epb41l3
erythrocyte membrane protein band 4.1-like 3
decreases expression
EXP
Nevirapine results in decreased expression of EPB41L3 mRNA
CTD
PMID:23947594
NCBI chr 9:109,056,178...109,260,607
Ensembl chr 9:109,016,113...109,260,607
G
Ereg
epiregulin
increases expression
ISO
Nevirapine results in increased expression of EREG mRNA
CTD
PMID:32816093
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
G
Esm1
endothelial cell-specific molecule 1
increases expression
EXP
Nevirapine metabolite results in increased expression of ESM1 mRNA; Nevirapine results in increased expression of ESM1 mRNA
CTD
PMID:23947594
NCBI chr 2:44,876,067...44,884,805
Ensembl chr 2:44,876,067...44,884,804
G
Fam107a
family with sequence similarity 107, member A
increases expression
EXP
Nevirapine results in increased expression of FAM107A mRNA
CTD
PMID:23947594
NCBI chr15:16,608,362...16,630,398
Ensembl chr15:16,607,205...16,630,396
G
Fibin
fin bud initiation factor homolog
increases expression
EXP
Nevirapine results in increased expression of FIBIN mRNA
CTD
PMID:23947594
NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676
G
Fkbp5
FKBP prolyl isomerase 5
increases expression
EXP
Nevirapine metabolite results in increased expression of FKBP5 mRNA; Nevirapine results in increased expression of FKBP5 mRNA
CTD
PMID:23947594
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
G
Fmo1
flavin containing dimethylaniline monoxygenase 1
decreases expression
EXP
Nevirapine metabolite results in decreased expression of FMO1 mRNA
CTD
PMID:23947594
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
G
Foxo1
forkhead box O1
increases expression
ISO
Nevirapine results in increased expression of FOXO1 mRNA
CTD
PMID:38636494
NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
increases expression
EXP ISO
Nevirapine results in increased expression of GADD45B mRNA
CTD
PMID:23947594 PMID:38636494
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
G
Gdf15
growth differentiation factor 15
multiple interactions increases expression
ISO
Nevirapine results in increased expression of and results in increased secretion of GDF15 protein Nevirapine results in increased expression of GDF15 mRNA
CTD
PMID:38636494
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
G
Glul
glutamate-ammonia ligase
decreases expression
EXP
Nevirapine metabolite results in decreased expression of GLUL mRNA
CTD
PMID:23947594
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
ISO
Mifepristone inhibits the reaction [Nevirapine results in increased secretion of and results in increased activity of GPT protein]; Nevirapine results in increased secretion of and results in increased activity of GPT protein
CTD
PMID:38636494
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gsta1
glutathione S-transferase alpha 1
increases glutathionylation
ISO
GSTA1 protein results in increased glutathionylation of Nevirapine metabolite
CTD
PMID:27989146
NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
G
Gstm1
glutathione S-transferase mu 1
increases glutathionylation
ISO
GSTM1 protein results in increased glutathionylation of Nevirapine metabolite
CTD
PMID:27989146
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Gstp1
glutathione S-transferase pi 1
increases glutathionylation
ISO
GSTP1 protein results in increased glutathionylation of Nevirapine metabolite
CTD
PMID:27989146
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Gzma
granzyme A
decreases expression
EXP
Nevirapine metabolite results in decreased expression of GZMA mRNA
CTD
PMID:23947594
NCBI chr 2:44,740,569...44,752,502
Ensembl chr 2:44,740,569...44,752,493
G
Gzmf
granzyme F
decreases expression
EXP
Nevirapine metabolite results in decreased expression of GZMF mRNA
CTD
PMID:23947594
NCBI chr15:30,005,361...30,018,649
Ensembl chr15:30,007,267...30,018,649
G
Hao2
hydroxyacid oxidase 2
decreases expression
EXP
Nevirapine metabolite results in decreased expression of HAO2 mRNA; Nevirapine results in decreased expression of HAO2 mRNA
CTD
PMID:23947594
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
G
Hdc
histidine decarboxylase
decreases expression
EXP
Nevirapine metabolite results in decreased expression of HDC mRNA
CTD
PMID:23947594
NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341
G
Hgf
hepatocyte growth factor
decreases secretion
ISO
Nevirapine results in decreased secretion of HGF protein
CTD
PMID:21619898
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2
increases expression
EXP
Nevirapine metabolite results in increased expression of HMGCS2 mRNA; Nevirapine results in increased expression of HMGCS2 mRNA
CTD
PMID:23947594
NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
G
Hpgd
15-hydroxyprostaglandin dehydrogenase
increases expression
EXP
Nevirapine metabolite results in increased expression of HPGD mRNA
CTD
PMID:23947594
NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
decreases expression
EXP
Nevirapine metabolite results in decreased expression of HSD17B2 mRNA
CTD
PMID:23947594
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
G
Hspa2
heat shock protein family A (Hsp70) member 2
increases expression
ISO
Nevirapine results in increased expression of HSPA2 mRNA
CTD
PMID:38636494
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
G
Ifng
interferon gamma
increases expression
ISO EXP
Nevirapine results in increased expression of IFNG protein
CTD
PMID:23947594
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igfbp1
insulin-like growth factor binding protein 1
increases expression multiple interactions
ISO
Nevirapine results in increased expression of IGFBP1 mRNA Nevirapine results in increased expression of and results in increased secretion of IGFBP1 protein
CTD
PMID:38636494
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
G
Igh-6
immunoglobulin heavy chain 6
increases expression
EXP
Nevirapine results in increased expression of IGH-6 mRNA
CTD
PMID:23947594
G
Ihh
Indian hedgehog signaling molecule
decreases expression
ISO
Nevirapine results in decreased expression of IHH mRNA
CTD
PMID:38636494
NCBI chr 9:76,504,315...76,510,532
Ensembl chr 9:76,504,315...76,510,532
G
Il1b
interleukin 1 beta
increases expression
ISO
Nevirapine results in increased expression of IL1B mRNA
CTD
PMID:32816093
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1r1
interleukin 1 receptor type 1
increases expression
ISO
Nevirapine results in increased expression of IL1R1 mRNA
CTD
PMID:38636494
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
G
Il22ra2
interleukin 22 receptor subunit alpha 2
increases expression
EXP
Nevirapine metabolite results in increased expression of IL22RA2 mRNA
CTD
PMID:23947594
NCBI chr 1:14,353,736...14,377,844
Ensembl chr 1:14,364,489...14,377,844
G
Il24
interleukin 24
increases expression
ISO
Nevirapine results in increased expression of IL24 mRNA
CTD
PMID:32816093
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
G
Il6
interleukin 6
decreases secretion
ISO
Nevirapine results in decreased secretion of IL6 protein
CTD
PMID:21619898
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Inhbe
inhibin subunit beta E
decreases expression
EXP ISO
Nevirapine metabolite results in decreased expression of INHBE mRNA Nevirapine results in decreased expression of INHBE mRNA
CTD
PMID:23947594 PMID:38636494
NCBI chr 7:63,176,221...63,179,209
Ensembl chr 7:63,176,219...63,179,172
G
Inmt
indolethylamine N-methyltransferase
increases expression
EXP
Nevirapine results in increased expression of INMT mRNA
CTD
PMID:23947594
NCBI chr 4:84,318,197...84,322,493
Ensembl chr 4:84,318,197...84,322,493
G
Insig2
insulin induced gene 2
increases expression
EXP
Nevirapine results in increased expression of INSIG2 mRNA
CTD
PMID:23947594
NCBI chr13:32,472,390...32,500,139
Ensembl chr13:32,473,742...32,494,923
G
Irf1
interferon regulatory factor 1
decreases expression
ISO
Nevirapine results in decreased expression of IRF1 mRNA
CTD
PMID:38636494
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
G
Irgm
immunity-related GTPase M
decreases expression
EXP
Nevirapine results in decreased expression of IRGM mRNA
CTD
PMID:23947594
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
G
Itga2
integrin subunit alpha 2
increases expression
ISO
Nevirapine results in increased expression of ITGA2 mRNA
CTD
PMID:38636494
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481
G
Itpr1
inositol 1,4,5-trisphosphate receptor, type 1
increases expression
EXP
Nevirapine results in increased expression of ITPR1 mRNA
CTD
PMID:23947594
NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Nevirapine results in increased expression of JUN mRNA
CTD
PMID:38636494
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Klf15
KLF transcription factor 15
increases expression
EXP
Nevirapine metabolite results in increased expression of KLF15 mRNA
CTD
PMID:23947594
NCBI chr 4:122,965,718...122,978,403
Ensembl chr 4:122,965,807...122,978,374
G
Klk1c10
kallikrein 1-related peptidase C10
increases expression
ISO
Nevirapine results in increased expression of KLK3 mRNA; Nevirapine results in increased expression of KLK3 protein
CTD
PMID:19152342
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
G
Krt18
keratin 18
increases expression
ISO
Nevirapine results in increased expression of KRT18 protein
CTD
PMID:19152342
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166 Ensembl chr10:133,157,475...133,161,166
G
Krt23
keratin 23
increases expression
EXP
Nevirapine metabolite results in increased expression of KRT23 mRNA
CTD
PMID:23947594
NCBI chr10:84,434,445...84,450,773
Ensembl chr10:84,434,380...84,450,983
G
Lcat
lecithin cholesterol acyltransferase
increases expression
ISO
Nevirapine results in increased expression of LCAT protein
CTD
PMID:19667106
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
G
Lcn2
lipocalin 2
increases expression
ISO
Nevirapine results in increased expression of LCN2 mRNA
CTD
PMID:38636494
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Ldaf1
lipid droplet assembly factor 1
decreases expression
EXP
Nevirapine results in decreased expression of LDAF1 mRNA
CTD
PMID:23947594
NCBI chr 1:174,484,438...174,503,037
Ensembl chr 1:174,484,447...174,503,036
G
Lep
leptin
increases expression
ISO
Nevirapine results in increased expression of LEP mRNA
CTD
PMID:21619898
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lhfpl2
LHFPL tetraspan subfamily member 2
decreases expression
ISO
Nevirapine results in decreased expression of LHFPL2 mRNA
CTD
PMID:38636494
NCBI chr 2:25,281,771...25,428,128
Ensembl chr 2:25,281,901...25,427,950
G
Lifr
LIF receptor subunit alpha
increases expression
EXP
Nevirapine metabolite results in increased expression of LIFR mRNA
CTD
PMID:23947594
NCBI chr 2:56,224,393...56,292,988
Ensembl chr 2:56,250,120...56,286,699
G
Lipg
lipase G, endothelial type
decreases expression
EXP
Nevirapine metabolite results in decreased expression of LIPG mRNA; Nevirapine results in decreased expression of LIPG mRNA
CTD
PMID:23947594
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
G
Lpin1
lipin 1
increases expression
EXP
Nevirapine metabolite results in increased expression of LPIN1 mRNA
CTD
PMID:23947594
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
G
Lpl
lipoprotein lipase
increases expression
ISO
Nevirapine results in increased expression of LPL mRNA
CTD
PMID:21619898
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Lrg1
leucine-rich alpha-2-glycoprotein 1
increases expression
EXP
Nevirapine metabolite results in increased expression of LRG1 mRNA
CTD
PMID:23947594
NCBI chr 9:947,516...949,773
Ensembl chr 9:947,516...949,813
G
Ly86
lymphocyte antigen 86
decreases expression
EXP
Nevirapine results in decreased expression of LY86 mRNA
CTD
PMID:23947594
NCBI chr17:27,415,807...27,499,695
Ensembl chr17:27,415,830...27,487,260
G
Meox2
mesenchyme homeobox 2
increases expression
EXP
Nevirapine results in increased expression of MEOX2 mRNA
CTD
PMID:23947594
NCBI chr 6:53,856,760...53,917,467
Ensembl chr 6:53,856,758...53,917,467
G
Met
MET proto-oncogene, receptor tyrosine kinase
increases expression
ISO
Nevirapine results in increased expression of MET mRNA
CTD
PMID:32816093
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Mfsd2a
MFSD2 lysolipid transporter A, lysophospholipid
increases expression
ISO
Nevirapine results in increased expression of MFSD2A mRNA
CTD
PMID:38636494
NCBI chr 5:135,225,801...135,240,744
Ensembl chr 5:135,225,816...135,240,690
G
Mgp
matrix Gla protein
increases expression
EXP
Nevirapine results in increased expression of MGP mRNA
CTD
PMID:23947594
NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667
G
Mrc1
mannose receptor, C type 1
increases expression
EXP
Nevirapine metabolite results in increased expression of MRC1 mRNA
CTD
PMID:23947594
NCBI chr17:77,249,187...77,330,857
Ensembl chr17:77,249,187...77,330,857
G
Ms4a7
membrane spanning 4-domains A7
decreases expression
EXP
Nevirapine results in decreased expression of MS4A7 mRNA
CTD
PMID:23947594
NCBI chr 1:207,969,117...207,984,743
Ensembl chr 1:207,968,761...207,983,260
G
Nampt
nicotinamide phosphoribosyltransferase
increases expression
EXP
Nevirapine metabolite results in increased expression of NAMPT mRNA
CTD
PMID:23947594
NCBI chr 6:49,425,316...49,462,109
Ensembl chr 6:49,424,332...49,462,100
G
Ndufaf4
NADH:ubiquinone oxidoreductase complex assembly factor 4
increases expression
EXP
Nevirapine results in increased expression of NDUFAF4 mRNA
CTD
PMID:23947594
NCBI chr 5:38,605,169...38,610,341
Ensembl chr 5:38,605,153...38,610,336
G
Nlrc5
NLR family, CARD domain containing 5
increases expression
ISO
Nevirapine results in increased expression of NLRC5
CTD
PMID:26626330
NCBI chr19:10,477,638...10,581,023
Ensembl chr19:10,477,628...10,562,121
G
Npas2
neuronal PAS domain protein 2
decreases expression
EXP
Nevirapine metabolite results in decreased expression of NPAS2 mRNA; Nevirapine results in decreased expression of NPAS2 mRNA
CTD
PMID:23947594
NCBI chr 9:41,463,361...41,642,322
Ensembl chr 9:41,463,830...41,642,320
G
Nptx2
neuronal pentraxin 2
increases expression
EXP
Nevirapine results in increased expression of NPTX2 mRNA
CTD
PMID:23947594
NCBI chr12:10,037,435...10,048,345
Ensembl chr12:10,037,435...10,048,345
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
decreases expression
EXP
Nevirapine metabolite results in decreased expression of NR1D1 mRNA
CTD
PMID:23947594
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
multiple interactions
ISO
[Nevirapine results in increased activity of NR1I3 protein alternative form] which results in increased expression of CYP2B6 mRNA; [Nevirapine results in increased activity of NR1I3 protein] which results in increased expression of CYP2B6 mRNA
CTD
PMID:17041008
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Nrep
neuronal regeneration related protein
decreases expression
EXP
Nevirapine metabolite results in decreased expression of NREP mRNA; Nevirapine results in decreased expression of NREP mRNA
CTD
PMID:23947594
NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591
G
Osgin1
oxidative stress induced growth inhibitor 1
decreases expression
ISO
Nevirapine results in decreased expression of OSGIN1 mRNA
CTD
PMID:38636494
NCBI chr19:47,471,750...47,500,517
Ensembl chr19:47,492,171...47,500,516
G
P2rx7
purinergic receptor P2X 7
decreases expression
EXP
Nevirapine results in decreased expression of P2RX7 mRNA
CTD
PMID:23947594
NCBI chr12:33,889,709...33,934,168
Ensembl chr12:33,879,745...33,934,619
G
Pcp4l1
Purkinje cell protein 4-like 1
decreases expression
EXP
Nevirapine results in decreased expression of PCP4L1 mRNA
CTD
PMID:23947594
NCBI chr13:83,588,992...83,612,631
Ensembl chr13:83,588,992...83,609,966
G
Pdk4
pyruvate dehydrogenase kinase 4
increases expression
EXP
Nevirapine metabolite results in increased expression of PDK4 mRNA
CTD
PMID:23947594
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
G
Pid1
phosphotyrosine interaction domain containing 1
increases expression
ISO
Nevirapine results in increased expression of PID1 mRNA
CTD
PMID:32816093
NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:85,284,335...85,503,044
G
Pik3ip1
phosphoinositide-3-kinase interacting protein 1
increases expression
EXP
Nevirapine results in increased expression of PIK3IP1 mRNA
CTD
PMID:23947594
NCBI chr14:78,204,668...78,216,616
Ensembl chr14:78,204,053...78,216,608
G
Pim3
Pim-3 proto-oncogene, serine/threonine kinase
increases expression
ISO
Nevirapine results in increased expression of PIM3 mRNA
CTD
PMID:38636494
NCBI chr 7:119,953,377...119,956,587
Ensembl chr 7:119,953,175...119,956,587
G
Pir
pirin
increases expression
EXP
Nevirapine metabolite results in increased expression of PIR mRNA
CTD
PMID:23947594
NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218
G
Pira2
paired-Ig-like receptor A2
decreases expression
EXP
Nevirapine results in decreased expression of PIRA2 mRNA
CTD
PMID:23947594
NCBI chr 1:65,352,125...65,422,842
Ensembl chr 1:65,415,946...65,422,853
G
Pla2g12a
phospholipase A2, group XIIA
increases expression
ISO
Nevirapine results in increased expression of PLA2G12A mRNA
CTD
PMID:38636494
NCBI chr 2:218,436,497...218,452,742
Ensembl chr 2:218,436,513...218,452,740
G
Plin4
perilipin 4
increases expression
ISO
Nevirapine results in increased expression of PLIN4 mRNA
CTD
PMID:38636494
NCBI chr 9:929,168...938,062
Ensembl chr 9:929,176...938,056
G
Pnpla2
patatin-like phospholipase domain containing 2
increases expression
EXP
Nevirapine metabolite results in increased expression of PNPLA2 mRNA
CTD
PMID:23947594
NCBI chr 1:196,552,723...196,557,805
Ensembl chr 1:196,552,723...196,557,805
G
Por
cytochrome p450 oxidoreductase
increases expression
EXP ISO
Nevirapine metabolite results in increased expression of POR mRNA; Nevirapine results in increased expression of POR mRNA
CTD
PMID:23947594 PMID:38636494
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
G
Pparg
peroxisome proliferator-activated receptor gamma
increases expression
ISO
Nevirapine results in increased expression of PPARG mRNA
CTD
PMID:21619898
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ppp2r2b
protein phosphatase 2, regulatory subunit B, beta
decreases expression
EXP
Nevirapine metabolite results in decreased expression of PPP2R2B mRNA; Nevirapine results in decreased expression of PPP2R2B mRNA
CTD
PMID:23947594
NCBI chr18:34,653,716...35,080,889
Ensembl chr18:34,653,721...35,081,025
G
Prf1
perforin 1
decreases expression
EXP
Nevirapine metabolite results in decreased expression of PRF1 mRNA
CTD
PMID:23947594
NCBI chr20:29,246,202...29,251,712
Ensembl chr20:29,246,202...29,251,701
G
Pycr1
pyrroline-5-carboxylate reductase 1
decreases expression
EXP
Nevirapine metabolite results in decreased expression of PYCR1 mRNA
CTD
PMID:23947594
NCBI chr10:105,917,732...105,922,658
Ensembl chr10:105,917,680...105,922,549
G
Rapgef4
Rap guanine nucleotide exchange factor 4
increases expression
ISO
Nevirapine results in increased expression of RAPGEF4 mRNA
CTD
PMID:38636494
NCBI chr 3:56,809,388...57,101,332
Ensembl chr 3:56,809,270...57,102,316
G
Rasd1
ras related dexamethasone induced 1
increases expression
ISO
Nevirapine results in increased expression of RASD1 mRNA
CTD
PMID:38636494
NCBI chr10:44,766,451...44,775,773
Ensembl chr10:44,766,455...44,768,186
G
Rbm3
RNA binding motif protein 3
increases expression
EXP
Nevirapine results in increased expression of RBM3 mRNA
CTD
PMID:23947594
NCBI chr X:14,348,909...14,352,387
Ensembl chr X:14,348,910...14,353,580
G
Retreg1
reticulophagy regulator 1
increases expression
EXP
Nevirapine metabolite results in increased expression of RETREG1 mRNA; Nevirapine results in increased expression of RETREG1 mRNA
CTD
PMID:23947594
NCBI chr 2:76,335,609...76,474,817
Ensembl chr 2:76,335,609...76,493,898
G
RGD1359108
similar to RIKEN cDNA 3110043O21
increases expression
ISO
Nevirapine results in increased expression of C9ORF72 mRNA
CTD
PMID:38636494
NCBI chr 5:49,766,340...49,791,434
Ensembl chr 5:49,766,325...49,791,408
G
Rgs16
regulator of G-protein signaling 16
increases expression
ISO
Nevirapine results in increased expression of RGS16 mRNA
CTD
PMID:38636494
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
G
Rhbdd2
rhomboid domain containing 2
increases expression
EXP
Nevirapine results in increased expression of RHBDD2 mRNA
CTD
PMID:23947594
NCBI chr12:21,043,605...21,054,305
Ensembl chr12:21,043,608...21,054,289
G
Rhobtb1
Rho-related BTB domain containing 1
increases expression
ISO
Nevirapine results in increased expression of RHOBTB1 mRNA
CTD
PMID:38636494
NCBI chr20:19,327,142...19,456,121
Ensembl chr20:19,327,155...19,403,012
G
Rprm
reprimo, TP53 dependent G2 arrest mediator homolog
decreases expression
EXP
Nevirapine metabolite results in decreased expression of RPRM mRNA
CTD
PMID:23947594
NCBI chr 3:38,539,581...38,540,998
Ensembl chr 3:38,539,581...38,540,998
G
S100a7a
S100 calcium binding protein A7A
increases expression
EXP
Nevirapine metabolite results in increased expression of S100A7A mRNA
CTD
PMID:23947594
NCBI chr 2:176,151,405...176,155,846
Ensembl chr 2:176,151,288...176,156,441
G
Scp2
sterol carrier protein 2
increases expression
ISO
Nevirapine results in increased expression of SCP2
CTD
PMID:26626330
NCBI chr 5:122,806,949...122,881,259
Ensembl chr 5:122,776,549...122,881,287
G
Sgk1
serum/glucocorticoid regulated kinase 1
increases expression
ISO
Nevirapine results in increased expression of SGK1 mRNA
CTD
PMID:38636494
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
G
Slamf9
SLAM family member 9
decreases expression
EXP
Nevirapine results in decreased expression of SLAMF9 mRNA
CTD
PMID:23947594
NCBI chr13:84,941,896...84,944,749
Ensembl chr13:84,941,982...84,944,748
G
Slc25a51
solute carrier family 25, member 51
increases expression
ISO
Nevirapine results in increased expression of SLC25A51 mRNA
CTD
PMID:38636494
NCBI chr 5:59,649,980...59,663,454
Ensembl chr 5:59,649,744...59,663,581
G
Slc34a2
solute carrier family 34 member 2
decreases expression
EXP
Nevirapine metabolite results in decreased expression of SLC34A2 mRNA
CTD
PMID:23947594
NCBI chr14:57,910,931...57,930,236
Ensembl chr14:57,910,480...57,930,436
G
Slc38a2
solute carrier family 38, member 2
increases expression
ISO
Nevirapine results in increased expression of SLC38A2 mRNA
CTD
PMID:38636494
NCBI chr 7:127,851,267...127,863,482
Ensembl chr 7:127,851,267...127,863,436
G
Slc5a5
solute carrier family 5 member 5
multiple interactions
ISO
[Nevirapine co-treated with TSHB protein] results in increased expression of SLC5A5 mRNA; [Nevirapine co-treated with TSHB protein] results in increased expression of SLC5A5 protein
CTD
PMID:16030158
NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
Nevirapine results in increased expression of SLC7A11 mRNA
CTD
PMID:32816093
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Srebf1
sterol regulatory element binding transcription factor 1
increases expression decreases expression
ISO EXP
Nevirapine results in increased expression of SREBF1 mRNA Nevirapine metabolite results in decreased expression of SREBF1 mRNA
CTD
PMID:21619898 PMID:23947594
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Sult1a1
sulfotransferase family 1A member 1
increases activity
EXP
Nevirapine metabolite results in increased activity of SULT1A1 protein; Nevirapine results in increased activity of SULT1A1 protein
CTD
PMID:27417440
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
G
Tat
tyrosine aminotransferase
increases expression
ISO
Nevirapine results in increased expression of TAT mRNA
CTD
PMID:38636494
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
G
Tg
thyroglobulin
increases expression
ISO
Nevirapine results in increased expression of TG mRNA; Nevirapine results in increased expression of TG protein
CTD
PMID:16030158
NCBI chr 7:98,418,293...98,603,210
Ensembl chr 7:98,418,293...98,603,210
G
Tgfb3
transforming growth factor, beta 3
increases expression
ISO
Nevirapine results in increased expression of TGFB3 mRNA
CTD
PMID:38636494
NCBI chr 6:105,704,058...105,726,661
Ensembl chr 6:105,704,236...105,726,564
G
Tmem64
transmembrane protein 64
increases expression
EXP
Nevirapine metabolite results in increased expression of TMEM64 mRNA; Nevirapine results in increased expression of TMEM64 mRNA
CTD
PMID:23947594
NCBI chr 5:28,698,947...28,745,384
Ensembl chr 5:28,698,918...28,745,330
G
Tnfaip6
TNF alpha induced protein 6
increases expression
ISO
Nevirapine results in increased expression of TNFAIP6 mRNA
CTD
PMID:32816093
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
G
Tnfrsf1b
TNF receptor superfamily member 1B
increases expression
ISO
Nevirapine results in increased expression of TNFRSF1B mRNA
CTD
PMID:38636494
NCBI chr 5:157,070,642...157,104,216
Ensembl chr 5:157,070,642...157,104,206
G
Tox3
TOX high mobility group box family member 3
increases expression
EXP
Nevirapine results in increased expression of TOX3 mRNA
CTD
PMID:23947594
NCBI chr19:16,648,338...16,757,151
Ensembl chr19:16,648,342...16,757,148
G
Tpo
thyroid peroxidase
increases expression
ISO
Nevirapine results in increased expression of TPO mRNA; Nevirapine results in increased expression of TPO protein
CTD
PMID:16030158
NCBI chr 6:46,698,402...46,768,199
Ensembl chr 6:46,698,414...46,768,199
G
Trim24
tripartite motif-containing 24
decreases expression
EXP
Nevirapine results in decreased expression of TRIM24 mRNA
CTD
PMID:23947594
NCBI chr 4:66,567,342...66,692,029
Ensembl chr 4:66,566,686...66,717,241
G
Trim63
tripartite motif containing 63
increases expression
EXP
Nevirapine metabolite results in increased expression of TRIM63 mRNA
CTD
PMID:23947594
NCBI chr 5:146,533,492...146,547,332
Ensembl chr 5:146,533,507...146,547,322
G
Tsc22d3
TSC22 domain family, member 3
increases expression
EXP
Nevirapine results in increased expression of TSC22D3 mRNA
CTD
PMID:23947594
NCBI chr X:104,217,898...104,277,886
Ensembl chr X:104,217,925...104,276,861
G
Tshb
thyroid stimulating hormone subunit beta
multiple interactions
ISO
[Nevirapine co-treated with TSHB protein] results in increased expression of SLC5A5 mRNA; [Nevirapine co-treated with TSHB protein] results in increased expression of SLC5A5 protein; Nevirapine promotes the reaction [TSHB protein affects the abundance of Iodine]; sodium perchlorate inhibits the reaction [Nevirapine promotes the reaction [TSHB protein affects the abundance of Iodine]]
CTD
PMID:16030158
NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
G
Tshr
thyroid stimulating hormone receptor
increases expression
ISO
Nevirapine results in increased expression of TSHR mRNA
CTD
PMID:16030158
NCBI chr 6:110,341,585...110,475,297
Ensembl chr 6:110,341,581...110,474,538
G
Tsku
tsukushi, small leucine rich proteoglycan
increases expression
EXP
Nevirapine results in increased expression of TSKU mRNA
CTD
PMID:23947594
NCBI chr 1:152,660,259...152,671,682
Ensembl chr 1:152,656,693...152,672,588
G
Ucp1
uncoupling protein 1
increases expression
ISO
Nevirapine results in increased expression of UCP1
CTD
PMID:16038477
NCBI chr19:24,808,782...24,816,853
Ensembl chr19:24,808,783...24,816,852
G
Ucp3
uncoupling protein 3
increases expression
EXP
Nevirapine metabolite results in increased expression of UCP3 mRNA
CTD
PMID:23947594
NCBI chr 1:154,815,777...154,828,764
Ensembl chr 1:154,815,777...154,828,762
G
Vcam1
vascular cell adhesion molecule 1
increases expression
EXP
Nevirapine metabolite results in increased expression of VCAM1 mRNA
CTD
PMID:23947594
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vegfa
vascular endothelial growth factor A
decreases expression
ISO
Nevirapine results in decreased expression of VEGFA mRNA
CTD
PMID:19152342
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vsnl1
visinin-like 1
decreases expression
EXP
Nevirapine metabolite results in decreased expression of VSNL1 mRNA; Nevirapine results in decreased expression of VSNL1 mRNA
CTD
PMID:23947594
NCBI chr 6:34,038,641...34,159,479
Ensembl chr 6:34,038,642...34,159,479
G
Zap70
zeta chain of T cell receptor associated protein kinase 70
increases expression
EXP
Nevirapine results in increased expression of ZAP70 mRNA
CTD
PMID:23947594
NCBI chr 9:38,989,750...39,011,701
Ensembl chr 9:38,989,750...39,011,700
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all